All groups showed a similar amount of activated CD4 and CD8 circulatory cells; however, the COVID-19 participants demonstrated a notably decreased number of the three main categories of circulatory monocytes: classic, intermediate, and non-classic [50]. This evidence concerns the gene CD8A and COVID-19.